OTCBB:SNANF
Sona Nanotech Inc. Stock News
$0.228
-0.0038 (-1.64%)
At Close: May 24, 2024
Sona's Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model
09:32am, Monday, 29'th Apr 2024
Halifax, Nova Scotia--(Newsfile Corp. - April 29, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces further results from the triple negative breast cancer murin
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
08:35am, Friday, 12'th Apr 2024
Halifax, Nova Scotia--(Newsfile Corp. - April 12, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce further positive interim results from its study
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
08:47am, Monday, 08'th Apr 2024
Halifax, Nova Scotia--(Newsfile Corp. - April 8, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces that it has been approved for funding totaling approximately
Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results
09:27am, Monday, 25'th Mar 2024
Halifax, Nova Scotia--(Newsfile Corp. - March 25, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces positive interim results from its study with The Giacomanton
Sona Nanotech Announces Filing of Provisional Patent Application
09:21am, Monday, 18'th Mar 2024
Halifax, Nova Scotia--(Newsfile Corp. - March 18, 2024) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has submitted a provisional patent application with
Sona Nanotech Grants Options
09:03am, Friday, 01'st Mar 2024
Halifax, Nova Scotia--(Newsfile Corp. - March 1, 2024) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that that it has granted 1,195,000 incentive stock options u
Sona Nanotech Announces Director Retirement
08:55am, Wednesday, 10'th Jan 2024
Halifax, Nova Scotia--(Newsfile Corp. - January 10, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") announces that Dr. Michael Gross has retired from the Company's Boar
Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing
08:59am, Monday, 27'th Nov 2023
Halifax, Nova Scotia--(Newsfile Corp. - November 27, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its private placement tha
Sona Nanotech Arranges Brokered Private Placement Financing
08:36am, Wednesday, 18'th Oct 2023
Halifax, Nova Scotia--(Newsfile Corp. - October 18, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce that it plans to raise up to $750,000 through a
Sona Provides Corporate Update on Operating Activities
01:21pm, Thursday, 12'th Oct 2023
Halifax, Nova Scotia--(Newsfile Corp. - October 12, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona"), a nanotechnology life sciences company with proprietary manufacturi
Halifax, Nova Scotia--(Newsfile Corp. - September 11, 2023) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce an innovative research initiative to be un
Sona to Engage with Medical Experts and Payors to Inform Regulatory and Commercialization Strategies for Its 'THT' Cancer Therapy
09:31am, Tuesday, 05'th Sep 2023
Halifax, Nova Scotia--(Newsfile Corp. - September 5, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce it has partnered with EXCITE International (
Sona Nanotech Grants Options
08:50am, Tuesday, 11'th Jul 2023
Halifax, Nova Scotia--(Newsfile Corp. - July 11, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF), (the "Company") is pleased to announce that it has granted 900,000 incentive stock options under
Sona Updates on Strategy and Test Development Progress
09:15am, Thursday, 23'rd Sep 2021
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021Halifax, Nov
Sona Discontinues Clinical Trial for COVID-19 Rapid Saliva Test
08:43am, Friday, 11'th Jun 2021
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021.- Encouragi